Tilman B. Drüeke

Active 1980–2024

96
Papers
19,324
Citations
78
h-index
96
i10-index

Citations

Citations per year for Tilman B. Drüeke1981: 2 citations1982: 5 citations1983: 9 citations1984: 8 citations1985: 8 citations1986: 4 citations1987: 11 citations1988: 5 citations1989: 14 citations1990: 11 citations1991: 16 citations1992: 19 citations1993: 16 citations1994: 14 citations1995: 32 citations1996: 30 citations1997: 37 citations1998: 30 citations1999: 58 citations2000: 47 citations2001: 66 citations2002: 59 citations2003: 77 citations2004: 103 citations2005: 99 citations2006: 80 citations2007: 94 citations2008: 159 citations2009: 117 citations2010: 103 citations2011: 106 citations2012: 98 citations2013: 112 citations2014: 108 citations2015: 98 citations2016: 92 citations2017: 110 citations2018: 98 citations2019: 423 citations2020: 378 citations2021: 368 citations2022: 245 citations2023: 164 citations2024: 261 citations2025: 118 citations2026: 5 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,196 citing papers, 22.3% of this breakdownUnited Kingdom: 367 citing papers, 6.8% of this breakdownFrance: 344 citing papers, 6.4% of this breakdownGermany: 307 citing papers, 5.7% of this breakdownItaly: 292 citing papers, 5.4% of this breakdownJapan: 267 citing papers, 5% of this breakdownChina: 258 citing papers, 4.8% of this breakdownSpain: 196 citing papers, 3.6% of this breakdownCanada: 180 citing papers, 3.4% of this breakdownNetherlands: 176 citing papers, 3.3% of this breakdownAustralia: 157 citing papers, 2.9% of this breakdownBelgium: 153 citing papers, 2.8% of this breakdown
0%22.3%Other 27.6%

Fields

  • Medicine81.6%
  • Biochemistry, Genetics and Molecular Biology8.8%
  • Nursing3.3%
  • Agricultural and Biological Sciences1.4%
  • Immunology and Microbiology1.3%
  • Neuroscience0.8%
  • Other2.8%

Topics

  • Parathyroid Disorders and Treatments12.7%
  • Dialysis and Renal Disease Management9.7%
  • Erythropoietin and Anemia Treatment4.9%
  • Magnesium in Health and Disease3.6%
  • Vitamin D Research Studies3.4%
  • Iron Metabolism and Disorders3%
  • Other62.7%

Coauthors

All papers

Open in search
  1. Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

    Authors: , , , , , , , , , - Kidney International 2006 cited by 1,973

  2. Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chuan‐Ming Hao, Kunitoshi Iseki, Joachim H. Ix, Kirsten L. Johansen, Markus Ketteler, Csaba P. Kövesdy, David E. Leaf, Iain C. Macdougall, Ziad A. Massy, Lawrence P. McMahon, Roberto Minutolo, Takeshi Nakanishi, Elizabeta Nemeth, Gregorio T. Obrador, Patrick S. Parfrey, Hyeong Cheon Park, Roberto Pecoits‐Filho, Bruce Robinson, Simon D. Roger, Yatrik Shah, Bruce Spinowitz, Tetsuhiro Tanaka, Yusuke Tsukamoto, Kriang Tungsanga, Carl P. Walther, Angela Yee‐Moon Wang, Myles Wolf - Kidney International 2021 cited by 209

  3. Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia

    Authors: , , , , , , , - New England Journal of Medicine 2006 cited by 2,096

  4. Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism

    Authors: , , , , , , , , , , , , , , - JAMA 2017 cited by 304

  5. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis

    Authors: , , , , , , , , , , , - American Journal of Kidney Diseases 2015 cited by 304

  6. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population

    Authors: , , , , , , , , , , , , - Nephrology Dialysis Transplantation 2010 cited by 475

  7. Summary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s)

    Authors: , - Kidney International 2012 cited by 224

  8. Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis

    Authors: , , , , , , , , , , , , , , - Circulation 2015 cited by 304

  9. Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis

    Authors: , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2014 cited by 210

  10. Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2004 cited by 1,132

  11. Changing bone patterns with progression of chronic kidney disease

    Authors: , - Kidney International 2016 cited by 219

  12. Advanced Oxidation Protein Products as Novel Mediators of Inflammation and Monocyte Activation in Chronic Renal Failure,

    Authors: , , , , , , , , , - The Journal of Immunology 1998 cited by 867

  13. Atherosclerosis in CKD: differences from the general population

    Authors: , - Nature Reviews Nephrology 2010 cited by 221

  14. Strategies for Phosphate Control in Patients With CKD

    Authors: , , , - Kidney International Reports 2019 cited by 128

  15. Combination of Cardiovascular, Kidney, and Metabolic Diseases in a Syndrome Named Cardiovascular-Kidney-Metabolic, With New Risk Prediction Equations

    Authors: , - Kidney International Reports 2024 cited by 53

  16. Sex and the Risk of Atheromatous and Nonatheromatous Cardiovascular Disease in CKD: Findings From the CKD-REIN Cohort Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Roberto Pecoits‐Filho, Bénédicte Stengel, Raymond Azar, Xavier Belenfant, Dominique Besnier, Jean Philippe Bourdenx, Stéphane Burtey, Dominique Chauveau, Charles Chazot, Gabriel Choukroun, Christian Combe, Michel Delahousse, Benjamin Deroure, Marie Essig, François Glowacki, Thierry Hannedouche, Maxime Hoffmann, Maryvonne Hourmant, Mohamed Jamali, Laurent Juillard, Nassim Kamar, Adrien Keller, Alexandre Klein, F Kuentz, Adeline Lacraz, G Lambrey, Isabelle Landru, Philippe Lang, Gaëtan Lebrun, Thierry Lobbedez, Éric Magnant, Sébastien Mailliez, Nathalie Maisonneuve, Séverine Martin, Bruno Moulin, Christian Noël, Viktor Panescu, Hacène Sekhri, Mustafa Smati, Angelo Testa, Éric Thervet, Pablo Ureña, Carlos Vela, Philippe Zaoui - American Journal of Kidney Diseases 2024 cited by 21

  17. Chronic Kidney Disease–Mineral-Bone Disorder: A New Paradigm

    Authors: , , , - Advances in Chronic Kidney Disease 2007 cited by 283

  18. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: A potential target for N-acetylcysteine treatment in dialysis patients

    Authors: , , , , , , - Kidney International 2003 cited by 232

  19. Hemodiafiltration Versus Hemodialysis and Survival in Patients With ESRD: The French Renal Epidemiology and Information Network (REIN) Registry

    Authors: , , , , , , , , , , - American Journal of Kidney Diseases 2015 cited by 86

  20. Calcimimetics increase CaSR expression and reduce mineralization in vascular smooth muscle cells: mechanisms of action

    Authors: , , , , , , , , , - Cardiovascular Research 2013 cited by 78

  21. Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism

    Authors: , , , , , , , , , , , , , , - JAMA 2017 cited by 153

  22. Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial

    Authors: , , , , , , , , , , , , , , , , - Journal of the American Heart Association 2014 cited by 139

  23. PROGRESS IN UREMIC TOXIN RESEARCH: Beta2‐Microglobulin

    Authors: , - Seminars in Dialysis 2009 cited by 103

  24. Direct, Acute Effects of Klotho and FGF23 on Vascular Smooth Muscle and Endothelium

    Authors: , , , , , , , - PLoS ONE 2014 cited by 138